Clinical Trial Update: Japanese Phase 1 Multiple Ascending Dose (MAD) Study [Phase 1]

View source ↗

Summary

Bristol-Myers Squibb completed a Japanese Phase 1 multiple ascending dose study for a depression candidate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Depression | Phase 1 | Status: COMPLETED